Poisons Act 1966 Proclamation amending Poisons List (1992-12) [GG No 7 of 17.1.1992] (NSW)

1992—No. 12

POISONS ACT 1966—PROCLAMATION

NEW SOUTH WALES

[Published in Gazette No. 7 of 17 January 1992]

(L.S.) P. R. SINCLAIR, Governor.

I, Rear Admiral PETER ROSS SINCLAIR, Governor of the State of New South Wales, with the advice of the Executive Council, on the recommendation of the Minister for Health and Community Services and in pursuance of section 8 (6) of the Poisons Act 1966, do, by this my Proclamation, amend the Poisons List as set forth in the Schedule hereunder with effect on and from 24 January 1992.

Signed and sealed at Sydney, this fifteenth day of January 1992.

By His Excellency’s Command,

JOHN HANNAFORD

Minister for Health and Community Services

GOD SAVE THE QUEEN!

SCHEDULE

The Poisons List is amended:

(a)	by deleting from Schedule Two the entry relating to MEFENAMIC ACID;
(b)	by deleting MEFENAMIC ACID from the list of excepted entries immediately following the heading to Schedule Three;
(c)	by deleting MEFENAMIC ACID from Schedule Four and from the list of excepted entries immediately following the heading to Schedule Four;

1992—No. 12

(d)	by omitting from the headings to each of Schedules One to Seven inclusive the matter “AMENDMENT Nos. 1 and 2” and by inserting instead the matter “AMENDMENT Nos. 1, 2 and 3”;
(e)	by deleting from Schedule Seven the entry relating to SELENIUM and by inserting instead the following entry:

SELENIUM except:

(a) when included in or expressly excluded from Schedule 5 or 6;

(b) as selenium arsenide in photocopier drums; or

(c) in preparations for therapeutic use.

(f) by inserting in Schedule Seven in appropriate alphabetical order the following entries:

ABRUS PRECATORIUS (Jequirity) seed or root for separately specified in this Schedule.
therapeutic use.
ANCHUSA OFFICINALIS for therapeutic use.
ARISTOLOCHIA spp. for therapeutic use.
BITHIONOL for human therapeutic use.
BORAGO OFFICINALIS (Borage) for therapeutic use
except the fixed oil derived from the seeds of Borago
officinalis.
CALCALIA spp. for therapeutic use.
CALAMUS for human therapeutic use.
CONINE.
COTARNINE.
CROTALARIA spp. for therapeutic use.
CYNOGLOSSUM OFFICINALE for therapeutic use.
CYNOGLOSSUM spp. for therapeutic use except when
separately specified in this Schedule.
DULCIN.
FARFUGIUM JAPONICUM for therapeutic use.
LIGULARIA DENTATA for therapeutic use.
HELIOTROPIUM RAMOSISSIMUM for therapeutic use.
HELIOTROPIUM spp. for therapeutic use except when
separately specified in this Schedule.
HELIOTROPWM SUPINUM for therapeutic use.
OXYPHENISATIN.
PETASITES JAPONICUM for therapeutic use.

1992—No. 12

PTERIDIUM AQUILINUM for therapeutic use.
PTERIDIUM spp. for therapeutic use except when
separately specified in this Schedule.
PULMONARIA spp. for therapeutic use.
SENECIO CANNABIFOLIUS for therapeutic use.
SENECIO JACOBAEA for therapeutic use.
SENECIO LONGILOBUS for therapeutic use.
SENECIO NUMORENSIS FUCHSII for therapeutic use.
SENECIO spp. for therapeutic use except when separately
specified in this Schedule.
SYMPHYTUM OFFICINALE (Comfrey) for therapeutic
use.
SYMPHYTUM spp. (Comfrey) for therapeutic use except
when separately specified in this Schedule.
TRICHODESMA AFRICANA for therapeutic use.

TUSSILAGO FARFARA for therapeutic use.

(g) by omitting from Schedule Eight the following substances:

ACETORPHINE.
CATHINONE.

DESOMORPHINE.

2,5-DIMETHOXY-4-BROMOAMPHETAMINE	(DOB).
2,5-DIMETHOXY-4-ETHYLAMPHETAMINE	(DOET).
HARMALINE. HARMINE. P-IODO-N-ISOPROBYLAMPHETAMINE. KETOBEMIDONE.